Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model (Q44287903)
scientific article published in January 2003
Language:
(P31) (Q13442814)
(P50) (Q39183791)
(P304) 45-50
(P407) (Q1860)
(P433) 1
(P478) 5
(P577) Wednesday, January 1, 2003
(P921) (Q271993)
(Q12252367)
(Q424771)
(P1433) (Q5270109)
(P1476) "Rosiglitazone (PPARgamma-agonist) attenuates atherogenesis with no effect on hyperglycaemia in a combined diabetes-atherosclerosis mouse model" (language: en)
(P2093) Shaish A
Yacov N
Levkovitz H
Trestman S
Gerber Y
Cohen H
Dvir A
Rhachmani R
Ravid M
Harats D
(P2860) (Q33762031)
(Q47070747)
(Q29620219)
(Q24311702)
(Q24311741)
(Q34479025)
(Q32085363)
other details
description scientific article published in January 2003

External Links